FDA adds warning to Ozempic label about risk for blocked intestines
Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
Sep 28, 2023
0
5
Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
Sep 28, 2023
0
5
Another diabetes drug maker is taking legal action against businesses in several states, alleging that they're "fraudulently claiming" that their compounded products are the same as its medication.
Sep 21, 2023
0
1
Patients with hemophilia A or B with inhibitors have a lower annualized bleeding rate with concizumab than with no prophylaxis, according to a phase 3 study published online Aug. 31 in the New England Journal of Medicine.
Sep 3, 2023
0
1
As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024. The new plan extends by months ...
Aug 14, 2023
0
23
Patients who take blockbuster drugs like Wegovy or Ozempic for weight loss may face life-threatening complications if they need surgery or other procedures that require empty stomachs for anesthesia. This summer's guidance ...
Aug 13, 2023
0
27
Losing weight conveniently, cheaply, safely. That's been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting's 1863 Letter on Corpulence promoted his "miraculous" ...
Aug 9, 2023
0
3
A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect.
Aug 8, 2023
0
33
Once-daily semaglutide 25 mg or 50 mg is superior to 14 mg for glycemic control among adults with type 2 diabetes, according to a study published online June 25 in The Lancet.
Aug 6, 2023
0
8
A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems.
Aug 3, 2023
0
1
Chronic kidney disease is a growing problem both in Denmark and internationally. Now, a new study from Aarhus University reveals that a protein known for treating cardiovascular diseases also counteracts a mechanism in the ...
Jul 10, 2023
0
0